Advanced Oncotherapy Past Earnings Performance
Past criteria checks 0/6
Advanced Oncotherapy's earnings have been declining at an average annual rate of -26%, while the Medical Equipment industry saw earnings growing at 4.2% annually.
Key information
-26.0%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | n/a |
| Return on equity | -53.9% |
| Net Margin | n/a |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Advanced Oncotherapy makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 0 | -33 | 26 | 0 |
| 31 Mar 22 | 0 | -31 | 25 | 0 |
| 31 Dec 21 | 0 | -29 | 24 | 0 |
| 30 Sep 21 | 0 | -28 | 23 | 0 |
| 30 Jun 21 | 0 | -26 | 22 | 0 |
| 31 Mar 21 | 0 | -26 | 21 | 0 |
| 31 Dec 20 | 0 | -25 | 20 | 0 |
| 30 Sep 20 | 0 | -24 | 20 | 0 |
| 30 Jun 20 | 0 | -22 | 19 | 0 |
| 31 Mar 20 | 0 | -21 | 20 | 0 |
| 31 Dec 19 | 0 | -21 | 21 | 0 |
| 30 Sep 19 | 0 | -21 | 20 | 0 |
| 30 Jun 19 | 0 | -21 | 20 | 0 |
| 31 Mar 19 | 0 | -21 | 20 | 0 |
| 31 Dec 18 | 0 | -21 | 20 | 0 |
| 30 Jun 18 | 0 | -18 | 18 | 0 |
| 31 Mar 18 | 0 | -16 | 16 | 0 |
| 31 Dec 17 | 0 | -14 | 14 | 0 |
| 30 Jun 17 | 0 | -12 | 15 | 0 |
| 31 Mar 17 | 0 | -11 | 14 | 0 |
| 31 Dec 16 | 0 | -10 | 13 | 0 |
| 30 Jun 16 | 0 | -8 | 10 | 0 |
| 31 Mar 16 | 0 | -7 | 9 | 0 |
| 31 Dec 15 | 0 | -6 | 8 | 0 |
| 30 Sep 15 | 0 | -7 | 7 | 0 |
| 30 Jun 15 | 0 | -7 | 6 | 0 |
| 31 Mar 15 | 0 | -6 | 6 | 0 |
| 31 Dec 14 | 0 | -6 | 5 | 0 |
| 30 Sep 14 | 0 | -5 | 4 | 0 |
| 30 Jun 14 | 0 | -5 | 4 | 0 |
| 31 Mar 14 | 0 | -4 | 3 | 0 |
| 31 Dec 13 | 0 | -3 | 2 | 0 |
| 30 Sep 13 | 0 | -2 | 1 | 0 |
| 30 Jun 13 | 0 | -2 | 1 | 0 |
| 31 Mar 13 | 0 | -2 | 1 | 0 |
| 31 Dec 12 | 0 | -2 | 1 | 0 |
Quality Earnings: R3I1 is currently unprofitable.
Growing Profit Margin: R3I1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if R3I1's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare R3I1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: R3I1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: R3I1 has a negative Return on Equity (-53.87%), as it is currently unprofitable.